VaccinesChildhood flu vaccination — what risks do vaccination critics see?
Sources: 9 · Article: 12 486 characters
The STOP NOP Association states that, in the study described, vaccinated children had 5.5 times as many cases of respiratory illness as children who received a placebo.
- The association also points to the possibility of encephalitis, permanent damage to the brain and immune system, and even death.
- It reports that vaccine effectiveness in the 2012/2013 season ranged from 9 to 56 percent, depending on the strain, and that vaccinated people can still become ill with the virus strain the vaccine was supposed to protect against.
- Jerzy Zięba claims that the flu vaccine is given to adults and children without clinical trials, while the STOP NOP Association points to limited knowledge about children who may be more susceptible to adverse effects from vaccination.
What the authors write
Stowarzyszenie STOP NOP
In the study of children described by the STOP NOP Association, the vaccinated group had 5.5 times as many cases of respiratory illness as the placebo group.
„Researchers conducted a double-blind, placebo-controlled study of children using a trivalent inactivated influenza vaccine. Their results were published in the journal Clinical Infectious Diseases in 2012, and showed that the seasonal flu vaccine caused 5.5 times as many cases of respiratory illness as occurred in the placebo group.”Naukowcy przeprowadzili badanie z podwójnie ślepą próbą z placebo na dzieciach z trójwartościową inaktywowaną szczepionką przeciwko grypie. Ich wyniki zostały opublikowane w czasopiśmie Clinical Infectious Diseases w 2012 r. i okazało się, że szczepionka przeciw sezonowej grypie spowodowała 5,5 razy więcej przypadków choroby układu oddechowego niż w grupie placebo.
Jerzy Zięba
Jerzy Zięba claims that the flu vaccine is given to adults and children without clinical trials.
„The flu vaccine is a drug that is introduced into the bodies of Polish adults and children without any clinical trial, not even the smallest one. It is the only “drug” (after all, it does not treat anything) that does not have to prove its effectiveness or, most importantly, its safety.”Szczepionka przeciw grypie jest właśnie lekiem wprowadzanym do organizmu Polaków dorosłych i dzieci bez żadnego badania klinicznego, nawet najmniejszego. Jest to jedyny „lek” (niczego przecież nie leczy), który nie wymaga wykazania jego skuteczności ani, co najważniejsze, jego bezpieczeństwa.
Stowarzyszenie STOP NOP
The STOP NOP Association reports that the effectiveness of the flu vaccine in the 2012/2013 season ranged from 9 to 56 percent, depending on the strain.
„Centers for Disease Control (2013)42
According to the CDC, the effectiveness of the flu vaccine in the 2012/2013 season ranged from 9 to 56 percent, depending on the strain. Older people had little or no immunity to the influenza A H3N2 strain.43 Flu symptoms: There are two main types of influenza (A and B). Symptoms include fever, chills, sore throat, fatigue, muscle and body aches, cough, diarrhea, and vomiting, and may last for more than a week.”Centers for Diseases Control (2013)42
Według CDC, skuteczność szczepionki przeciwko grypie w sezonie 2012/2013 wynosiła od 9 do 56 procent, w zależności od szczepu, przy czym osoby starsze uzyskiwały słabą odporność przeciwko szczepowi grypy A H3N2, lub nie miały jej wcale.43Objawy grypy: Istnieją dwa główne rodzaje grypy (A i B), których objawy obejmują gorączkę, dreszcze, ból gardła, zmęczenie, ból mięśni i ciała, kaszel, biegunkę i wymioty, które mogą utrzymywać się nawet ponad tydzień.
Stowarzyszenie STOP NOP
The STOP NOP Association says that vaccination may be associated with encephalitis, permanent damage to the brain and immune system, and even death.
„in public health policy-making and in shared medical decisions made by doctors and patients.7 8
VACCINATION: KNOW THE RISKS
As was the case with the first smallpox vaccine, every vaccine currently recommended by government health officials and medical associations carries a risk of complications, such as encephalitis, which can lead to chronic damage to the brain and immune system, and even death.9 10 11 12 13”w zakresie tworzenia polityki zdrowia publicznego oraz w zakresie wspólnych decyzji medycznych podejmowanych przez lekarzy i pacjentów.7 8
SZCZEPIENIA: POZNAJ RYZYKO
Jak miało to miejsce w przypadku pierwszej szczepionki przeciwko ospie prawdziwej, każda szczepionka współcześnie zalecana przez urzędników rządowych resortu zdrowia i stowarzyszenia medyczne wiąże się z ryzykiem powikłań, takich jak zapalenie mózgu, które mogą prowadzić do przewlekłych uszkodzeń mózgu i układu odpornościowego, a nawet do śmierci.9 10 11 12 13
Stowarzyszenie STOP NOP
The STOP NOP Association points to limited knowledge about children who may be more susceptible to adverse effects from vaccination.
„The committee found that evidence on assessing outcomes in subgroups of children who may be potentially susceptible to adverse effects from vaccination (such as children with a family history of autoimmune diseases or allergies, or children born prematurely) is limited, and that there is uncertainty about how such a population, exposure, or outcomes should be defined.??”Komisja stwierdziła, że dowody w zakresie oceny wyników subpopulacji dzieci, które mogą być potencjalnie podatne na działania niepożądane szczepień (jak w przypadku dzieci, w których wywiadzie rodzinnym występują choroby autoimmunologiczne lub alergie lub dzieci urodzone przedwcześnie) są ograniczone i cechuje je niepewność w zakresie definicji takiej populacji oraz definicji narażenia czy skutków.??
Stowarzyszenie STOP NOP
The STOP NOP Association reports that people vaccinated against flu can still become ill with the virus strain the vaccine was supposed to protect against.
„Flu vaccine: Limited effectiveness
?Unfortunately, some people may become infected with the flu virus strain the flu vaccine is intended to protect against, even after vaccination. The protection provided by the flu vaccine may vary, partly depending on the health and age of the person vaccinated.?”Szczepionka przeciwko grypie: Ograniczona skuteczność
?Niestety niektórzy mogą zakazić się szczepem wirusa grypy przeciwko któremu szczepionka przeciwko grypie ma chronić nawet pomimo szczepienia. Ochrona zapewniona przez szczepionkę przeciwko grypie może być różna, w zależności częściowo od stanu zdrowia i wieku osoby szczepionej.?
Research from PubMed · Europe PMC
We selected 3 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 2 196.
After vaccination, the most commonly reported effects in children were a runny nose or pain at the injection site. These effects were usually short-lived and rarely interfered with daily life.
Aim of the study: During the 2022-23 season, three autonomous communities recommended influenza vaccination for all children between 6 and 59 months. The objective is to evaluate the adverse effects associated with the administered influenza vaccines in the Region of Murcia, as well as their influence on the recommendation of the same to acquaintances or repetition in future seasons.
Results: Among 4971 surveys received, the most common adverse effect for LAIV and IIV was runny nose (40.90%) and local pain (31.94%), respectively. Sixty percent of adverse effects lasted ≤ 1 day, and around 10% lasted ≥ 3 days. The interference of adverse effects with the minor's daily life was very infrequent (3.32%), as was the need for visiting the medical office (2.68%). Overall, 96.44% of parents would recommend influenza vaccination to friends and relatives after the experience. Only 3.56% would not recommend it, while 1.68% would not vaccinate their child against influenza again. The most frequently cited reason being adverse effects. Our study shows the safety of influenza vaccines. Despite the low impact of adverse effects, they influence some parents in their intention to continue vaccinating or recommending it to acquaintances, which remarks the need to reinforce the information given to parents so that this fact does not influence decision-making.
Money for the studycompany or manufacturer · AstraZeneca Spain, AstraZeneca España
Do the authors have ties to companies?yes — the authors reported it
Did a manufacturer help with the study?YES
Type of studyobservation of people
Participants4 971
“Not stated” does not mean nobody paid — the database does not always record it.
After the intranasal flu vaccine, most reported adverse effects were mild, although some children experienced symptoms that affected their daily activities, and one child needed emergency care.
Aim of the study: No data have been collected regarding the quality of life after live-attenuated influenza vaccine (LAIV). Our study investigates LAIV's impact on the quality of life of children.
Results: The EQ-5D-Y-3L score also declined, however, only on day 1 and recovered faster, reaching the pre-vaccination value already on day 5, undulating around the baseline level until day 10. A net loss of 0.01 quality-adjusted life days was identified (AUC: -0.0138). Our analysis showed a positive LAIV safety profile. Data from larger populations are needed to support clinical recommendations, promoting vaccine acceptance and fighting hesitancy.
Money for the studyuniversity or foundation · Public Promoting Association, Kobayashi Aoitori Foundation
Do the authors have ties to companies?yes — the authors reported it
Did a manufacturer help with the study?YES
Type of studyclinical study in people
Participants92
“Not stated” does not mean nobody paid — the database does not always record it.
The review describes a theoretical risk that a post-vaccination immune response could worsen respiratory disease, but says that existing vaccines are safe and effective; it does not present evidence of such a risk in children vaccinated against flu.
Aim of the study: Vaccines are a safe and highly effective tool for protecting both humans and animals against infectious diseases. Although vaccines currently in use in humans have robust safety records, historical examples show that some vaccines have resulted in adverse outcomes, including vaccine-associated enhanced respiratory disease (VAERD).
Results: Notable cases of VAERD have been associated with a respiratory syncytial virus vaccine candidate evaluated in clinical trials in the 1960s, experimental coronavirus vaccines in animal models, and in veterinary vaccines for influenza virus in swine. Existing approved vaccines are safe and highly effective tools for protecting both humans and animals against respiratory pathogens. However, as new respiratory vaccines are developed, they must also undergo careful testing for VAERD or other adverse outcomes. This review aims to provide the field with an overview of VAERD as a resource to support vaccine development and safety studies.
Money for the studygovernment, public institutions · National Institutes of Health, University of North Carolina School of Medicine, Rapidly Emerging Antiviral Drug Development Initiative (READDI)
Do the authors have ties to companies?yes — the authors reported it
Did a manufacturer help with the study?YES
Type of studydiscussion of other studies
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Orthomolecular Medicine News Service Opinion material
„By 1962 the government vaccination program for children and adolescents required 5 doses (OPV, Smallpox, DTP), by 1983 this had been increased to 24 doses. In 1986, President Ronald Reagan passed a law (National Vaccine Harm to Children Act) to grant vaccine manufacturers immunity from lawsuits over deaths or injuries resulting from vaccines. This law created a compensation fund from which around 5 billion has been paid for damages from vaccines, which is estimated to be a fraction of the true current damages [5,6]. After 1986 there was rapid growth in the number of vaccines recommended as necessary.”By 1962 the government vaccination program for children and adolescents required 5 doses (OPV, Smallpox, DTP), by 1983 this had been increased to 24 doses. In 1986, President Ronald Reagan passed a law (National Vaccine Harm to Children Act) to grant vaccine manufacturers immunity from lawsuits over deaths or injuries resulting from vaccines. This law created a compensation fund from which around 5 billion has been paid for damages from vaccines, which is estimated to be a fraction of the true current damages [5,6]. After 1986 there was rapid growth in the number of vaccines recommended as necessary.
Orthomolecular Medicine News Service Opinion material
„(OMNS Apr 8, 2011) "No pharmaceutical drug is devoid of risks from adverse reactions and vaccines are no exception. Vaccination is a medical intervention and should be carried out with the informed consent of those who are being subjected to it." (Dr. Lucija Tomljenovic, University of British Columbia.) At a conference held in London this month by the British Society for Ecological Medicine, the main topic was vaccinations. Not one person speaking was anti-vaccination; most said they were in favor of vaccination, but even more so of vaccine safety.”(OMNS Apr 8, 2011) "No pharmaceutical drug is devoid of risks from adverse reactions and vaccines are no exception. Vaccination is a medical intervention and should be carried out with the informed consent of those who are being subjected to it." (Dr. Lucija Tomljenovic, University of British Columbia.) At a conference held in London this month by the British Society for Ecological Medicine, the main topic was vaccinations. Not one person speaking was anti-vaccination; most said they were in favor of vaccination, but even more so of vaccine safety.
Orthomolecular Medicine News Service Opinion material
„His work continues to influence discussions on vaccine policy and public health. References: 1. Goldman, G. S. & Cheng, R. Z. The Immature Infant Liver: Cytochrome P450 Enzymes and their Relevance to Vaccine Safety and SIDS Research. Int J Med Sci 22, 2434-2445 (2025). 2. WHO. Immunization coverage. 3. Hill, H. A. Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 - National Immunization Survey-Child, United States, 2020-2022. MMWR Morb Mortal Wkly Rep 72, (2023). 4. Zhou, S.-F., Liu, J.-P. & Chowbay, B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41, 89-295 (2009). 5.”His work continues to influence discussions on vaccine policy and public health. References: 1. Goldman, G. S. & Cheng, R. Z. The Immature Infant Liver: Cytochrome P450 Enzymes and their Relevance to Vaccine Safety and SIDS Research. Int J Med Sci 22, 2434-2445 (2025). 2. WHO. Immunization coverage. 3. Hill, H. A. Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 - National Immunization Survey-Child, United States, 2020-2022. MMWR Morb Mortal Wkly Rep 72, (2023). 4. Zhou, S.-F., Liu, J.-P. & Chowbay, B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41, 89-295 (2009). 5.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.